Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$646M |
| 2 |
Tesla
TSLA
|
+$572M |
| 3 |
Broadcom
AVGO
|
+$521M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$478M |
| 5 |
lululemon athletica
LULU
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$861M |
| 3 |
Palantir
PLTR
|
+$730M |
| 4 |
iShares Bitcoin Trust
IBIT
|
+$576M |
| 5 |
NVIDIA
NVDA
|
+$443M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.35% |
| 2 | Technology | 1.74% |
| 3 | Consumer Discretionary | 0.9% |
| 4 | Financials | 0.71% |
| 5 | Communication Services | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLRX
11701
PUT
BioLineRX
BLRX
$11.4M
| $76.4K | ﹤0.01% |
+20,200
| New | +$81K |
|
11702
Savara
SVRA
$1.08B
| $76.3K | ﹤0.01% |
21,364
-138,715
| -87% | -$410K |
|
11703
CALL
CI&T Inc
CINT
$439M
| $76.2K | ﹤0.01% |
14,800
-1,100
| -7% | -$5.96K |
|
11704
PUT
Direxion Daily TSLA Bear 1X ETF
TSLS
$64.3M
| $75.9K | ﹤0.01% |
1,410
-320
| -18% | -$22.9K |
|
11705
PUT
Voyager Therapeutics
VYGR
$218M
| $75.7K | ﹤0.01% |
16,200
-6,500
| -29% | -$23.5K |
|
11706
Standard BioTools
LAB
$252M
| $75.6K | ﹤0.01% |
58,138
-340,715
| -85% | -$446K |
|
11707
PUT
PetMed Express
PETS
$40.8M
| $75.6K | ﹤0.01% |
30,100
+6,300
| +26% | +$19.5K |
|
11708
CALL
Ovid Therapeutics
OVID
$547M
| $75.5K | ﹤0.01% |
+58,100
| New | +$50.4K |
|
11709
PUT
BlackRock TCP Capital
TCPC
$346M
| $75K | ﹤0.01% |
12,100
-44,900
| -79% | -$322K |
|
11710
PUT
Quanterix
QTRX
$125M
| $74.9K | ﹤0.01% |
+13,800
| New | +$73.4K |
|
11711
NanoViricides
NNVC
$31.7M
| $74.7K | ﹤0.01% |
+52,217
| New | +$78.2K |
|
11712
Reading International Class A
RDI
$46M
| $74.6K | ﹤0.01% |
50,721
-39,725
| -44% | -$56.2K |
|
11713
PUT
SurgePays
SURG
$4.35M
| $74.5K | ﹤0.01% |
26,500
+2,800
| +12% | +$7.94K |
|
11714
MMTec
MTC
$377M
| $74.4K | ﹤0.01% |
89,595
+77,625
| +648% | +$72.9K |
|
|
CMRC
11715
CALL
Commerce.com Inc Series 1
CMRC
$207M
| $74.4K | ﹤0.01% |
14,900
-21,700
| -59% | -$104K |
|
11716
Eledon Pharmaceuticals
ELDN
$260M
| $74.3K | ﹤0.01% |
28,700
-990,219
| -97% | -$2.89M |
|
11717
PUT
Gossamer Bio
GOSS
$83.2M
| $74.2K | ﹤0.01% |
+28,200
| New | +$62.2K |
|
11718
Koss Corp
KOSS
$33.1M
| $74K | ﹤0.01% |
+14,558
| New | +$82.4K |
|
11719
Inhibikase Therapeutics
IKT
$336M
| $73.9K | ﹤0.01% |
45,605
-337,466
| -88% | -$585K |
|
|
PPSI
11720
Pioneer Power Solutions
PPSI
$31.9M
| $73.8K | ﹤0.01% |
+17,078
| New | +$61.3K |
|
11721
Invivyd
IVVD
$284M
| $73.7K | ﹤0.01% |
66,984
-162,348
| -71% | -$144K |
|
11722
Lesaka Technologies
LSAK
$396M
| $73.5K | ﹤0.01% |
+17,721
| New | +$80.1K |
|
|
11723
PUT
Invivyd
IVVD
$284M
| $73.5K | ﹤0.01% |
+66,800
| New | +$59.2K |
|
11724
PUT
Heron Therapeutics
HRTX
$62M
| $73.5K | ﹤0.01% |
58,300
+31,200
| +115% | +$49.5K |
|
11725
Hitek Global
HKIT
$26.8M
| $73.3K | ﹤0.01% |
+11
| New | +$63.9K |
|
Similar funds
Jeff Yass's Q3 2025 Portfolio in Review
As of Q3 2025, Jeff Yass held 14,336 positions worth $875B, up 22% from $720B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q3 2025 filing shows 1,794 new, 5,240 increased, 5,148 reduced and 2,105 closed positions. Its largest new stake was BitMine Immersion Technologies: 7,689,603 shares worth $399M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 94% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2025 buy was BitMine Immersion Technologies: 7,689,603 shares worth $399M.
- Jeff Yass added most to Meta Platforms (Facebook) in Q3 2025, an estimated $646M increase.
- Jeff Yass's biggest Q3 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Jeff Yass fully exited iShares Core MSCI Total International Stock ETF in Q3 2025, selling an estimated $123M.
- Jeff Yass's ten largest holdings make up 24% of its $875B portfolio in Q3 2025.
- Jeff Yass opened 1,794 new positions and closed 2,105 in Q3 2025.
- Jeff Yass's portfolio value rose 22% quarter-over-quarter to $875B.
Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.